Immediate Impact
1 by Nobel laureates 63 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Drug repurposing for cancer therapy
2024 Standout
Works of Corey C. Foster being referenced
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Corey C. Foster | 358 | 193 | 218 | 229 | 38 | 628 | |
| E. Cellai | 259 | 166 | 304 | 160 | 23 | 581 | |
| William T. Moss | 251 | 325 | 187 | 210 | 43 | 730 | |
| Ömer Uzel | 247 | 213 | 266 | 146 | 34 | 604 | |
| Milford D. Schulz | 271 | 306 | 134 | 329 | 26 | 709 | |
| Sati Akbaba | 230 | 282 | 146 | 244 | 44 | 605 | |
| Michelle Echevarria | 243 | 107 | 156 | 244 | 29 | 519 | |
| Emmanuelle Tresch | 304 | 208 | 115 | 172 | 44 | 611 | |
| R.D. Errington | 179 | 274 | 302 | 228 | 26 | 697 | |
| Louis Tak Lui | 248 | 272 | 364 | 224 | 25 | 687 | |
| Michael A. Papagikos | 402 | 124 | 121 | 163 | 24 | 617 |
All Works
Login with ORCID to disown or claim papers
Loading papers...